Parotitis due to oxyphenylbutazone therapy

R. Eliakim, R. Stalnikowicz

Research output: Contribution to journalArticlepeer-review


A patient who developed acute bilateral parotid enlargement after ingestion of three tablets of oxyphenylbutazone for the first time is reported. There was dryness of the mouth and swelling of the mucous membranes of the mouth and larynx. All symptoms disappeared immediately after withdrawal of the drug and administration of prednisone. Unlike phenylbutazone, parotitis is a rare complication of oxyphenylbutazone therapy.

Original languageEnglish
Pages (from-to)361-362+382
Issue number12
StatePublished - 1981
Externally publishedYes


Dive into the research topics of 'Parotitis due to oxyphenylbutazone therapy'. Together they form a unique fingerprint.

Cite this